Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Brain Injuries » Brain Injuries, Traumatic
Diseases [C] » Nervous System Diseases [C10] » Trauma, Nervous System » Craniocerebral Trauma » Brain Injuries » Brain Injuries, Traumatic
Diseases [C] » Wounds and Injuries [C26] » Trauma, Nervous System » Craniocerebral Trauma » Brain Injuries » Brain Injuries, Traumatic
Description
A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain. MeSH
Hierarchy View
Subtype Terms (3)
Brain Concussion
32 drugs (21 approved, 11 experimental)
Brain Contusion
3 drugs (2 approved, 1 experimental)
Chronic Traumatic Encephalopathy
7 drugs (4 approved, 3 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (40)
Phase 3 Indicated Drugs (29)
Phase 2 Indicated Drugs (52)
Other Experimental Indicated Drugs (23)
Organization Involved with Phase 4 Indications (64)
Mayfield Clinic & Spine Institute
Methodist Rehabilitation Center
National Center for Research Resources (NCRR)
Ontario Mental Health Foundation
Ontario Neurotrauma Foundation
Ospedale Maggiore San Giovanni Bosco
Shahid Beheshti University of Medical Sciences
Swiss National Science Foundation
The First People's Hospital of Lianyungang
Organization Involved with Phase 3 Indications (81)
Australian and New Zealand Intensive Care Society Clinical Trials Group
Canadian Department of National Defense
Canadian Institutes of Health Research (CIHR)
Cristália Produtos Químicos Farmacêuticos Ltda.
Defence Research and Development Canada
Direction Centrale du Service de Santé des Armées
Fondo de Investigacion Sanitaria
Heart and Stroke Foundation of Canada
Hospital Universitari Son Dureta
Irish Critical Care Clinical Trials Network
JP Moulton Charitable Foundation
Medical Research Future Fund (MRFF)
Moss Rehabilitation Research Institute
National Health and Medical Research Council, Australia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institutes of Health (NIH)
National University of Ireland
Neurological Emergencies Treatment Trials Network
Pediatric Emergency Care Applied Research Network
Pharmaceutical Research Associates, Inc. (PRA)
Organization Involved with Phase 2 Indications (65)
Hoosier Cancer Research Network
Lieber Institute for Brain Development (LIBD)
Mashhad University of Medical Sciences
National Institute of Nursing Research (NINR)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Oregon Health and Science University
Rehabilitation Hospital of Indiana
South East Sydney and Illawarra Area Health Service
Uniformed Services University of Health Sciences
Uniformed Services University of the Health Sciences
Organization Involved with Phase 1 Indications (26)
Organization Involved with Other Experimental Indications (23)
International Atomic Energy Agency
Katholieke Universiteit Leuven
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
